Pancreatic Cancer Research

ResearcherRutgers, The State University of New JerseyNo recent work listed

Zhiyong Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8576-1607; OpenAlex author ID A5100352583. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: 1 paper

Papers 5

  1. Retraction of "SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis". Co-author DOI 10.1515/med-2023-0890↗
  2. SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis. Co-author DOI 10.1515/med-2022-0418↗
  3. Progress and prospects for use of cellular immunotherapy in pancreatic cancer. Co-author DOI 10.4103/jcrt.jcrt_976_21↗
  4. HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion. Last author DOI 10.18632/oncotarget.15529↗
  5. MiR-371-5p facilitates pancreatic cancer cell proliferation and decreases patient survival. Last author DOI 10.1371/journal.pone.0112930↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Weidong Jin · 2 shared papers, 2022–2023 · strength 0.40
  2. Zhonghu Li · 2 shared papers, 2022–2023 · strength 0.40
  3. Jianxin Zhang · 1 shared paper, 2023 · strength 0.22
  4. Jianxin Zhang · 1 shared paper, 2022 · strength 0.19
  5. Jing Tian · 1 shared paper, 2022 · strength 0.17
  6. Bin Yan · 1 shared paper, 2022 · strength 0.17
  7. De He · 2 shared papers, 2014–2017 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.